ELAB Competitors & Alternatives
Compare Elevai Labs, Inc. Common Stock with similar stocks in the same industry
Biotechnology
ELAB
Main Stock$1.18
Tradestie Score
45
Market Cap
$3.50M
Revenue Growth
-0.5%
Top Competitors
237 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ANRO
Alto Neuroscience Inc.
|
$24.78
|
$110.20M | - | 58 | Compare |
|
OVID
Ovid Therapeutics Inc. Common Stock
|
$2.69
|
$97.42M | - | 55 | Compare |
|
STRO
Sutro Biopharma, Inc.
|
$30.43
|
$76.55M | - | 58 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$6.28
|
$71.69M | - | 52 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$10.34
|
$67.94M | - | 56 | Compare |
|
ATPC
Agape ATP Corporation Common Stock
|
$2.83
|
$60.51M | 6.6 | 52 | Compare |
|
XPON
Expion360 Inc. Common Stock
|
$0.45
|
$12.78M | - | 49 | Compare |
|
BDRX
Biodexa Pharmaceuticals plc American Depositary Shs
|
$2.94
|
$4.10M | - | 50 | Compare |
|
NIVF
NewGenIvf Group Limited Class A ordinary shares
|
$0.46
|
$4.04M | 0.0 | 46 | Compare |
|
NEXR
NEXR
|
$0.64
|
- | - | 51 | Compare |
More ELAB Analysis
Data updated: Jul 02, 2026 | Industry: Biotechnology (SIC 2834)
237 stocks in this industry